白细胞介素2治疗高血压的效应

Antihypertensive Effects of Interleukin 2

  • 摘要: 测定20例晚期癌肿患者白介素2(ILZ)治疗前后血压、血清IgG,C:及T淋巴细胞亚群变化。其中10例伴有高血压病(*H);另ic倒无*H(Non-*H)。结果表明,问川\剂量IL2即能使EH者血压降至正常水平,其降压效应可持续1个月以上;Non-EH组无明显降压效应。(2)ILZ治疗前,EH组与Non-EH组比较IgG明显增高(P<0.05),C。及CDS明显降低(P<0.05)。()EH组血压与IgG呈显著正相关计一0.78),与CDS是显著负相关计—-0.67)。提示IL-2可能通过调节EH免疫功能产生降压效应。

     

    Abstract: Serum IgG, C3, T-lymphocyte subgroups and SBP, DBP were determined in 20 patients before and after treatment with lnter1eukin 2. Among them, 10 cases were ill with advanced carcinoma and essential hypertension (EH),and the other 10 had advanced carcinoma with non-EH. The results showed that : (1)Small dose administration of IL2 lowered the blood pressure to normal level in EH and the hypotensive effects of IL2 cou1d persist for at least 1 month with no toxic or untoward effects. BP in non-EH was not affected by IL2.(2)Serum IgG in EH was much higher than that in non-EH group (P<0. 05). Serum C3 and CD8 in EH were much lower than those in non-EH group (P< 0. 05 ). (3)Linear positive correlation was found between BP and Serum IgG (r= 0. 78) in EH, while linear negative correlation was found between BP and CD, (r = - 0. 67 ). These results suggest that the hypotensive effects of IL2 are brought about by adjusting immunological system function in EH.

     

/

返回文章
返回